Metabolic management of microenvironment acidity in glioblastoma.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic theoretical framework with no new human empirical data.
PubMed 36059707 · doi:10.3389/fonc.2022.968351
What was done
This is a narrative review synthesizing evidence on glioblastoma (GBM) metabolic dependency on fermentation of glucose and glutamine driven by mitochondrial defects. The authors describe how fermentation waste products (lactic acid, glutamic acid, and succinic acid) drive tumor microenvironment acidification and discuss metabolic targeting strategies.
What was found
The abstract reports no empirical numbers or quantitative findings. It presents the mechanism by which conventional therapies (radiation, chemotherapy, steroids) may promote microenvironmental acidification and recurrence, and proposes that simultaneous restriction of glucose and glutamine with elevation of ketone bodies restores microenvironmental pH balance.
Why it matters
The paper presents a theoretical framework for exploiting tumor metabolic dependencies and microenvironmental acidity as a non-toxic adjunct strategy in glioblastoma.
Limits
The abstract describes a mechanistic hypothesis with no new empirical data, clinical trial outcomes, or quantified patient metrics. The safety, feasibility, and therapeutic efficacy of combined glucose-glutamine restriction in humans require prospective experimental evaluation.
Cited by
- supports Lactic acid and succinic acid produced by tumor fermentation protect tumor cells from chemotherapy and radiation.